OPINION – How to get around the current crisis in Brazil
By Biominas Brasil and Serpa Group We all know that 2015 was a year of economic crisis in Brazil. Political instability, rising inflation, low growth of the productive sectors and the rise in the US dollar against Brazilian the currency contributed to the uncomfortable situation for many sectors of our economy. However, the pharmaceutical industry, […]
Data Snapshot: Dwarfed By Big Pharma, Biotech By The Numbers
Biotech fills the news these days – whether it’s the announcement of exciting new clinical data, another high-flying IPO, or a big M&A deal. Amidst the significant “share of voice” in the coverage of young and emerging biotech in the media, it’s easy to forget the relative scale of the sector relative to larger BioPharma […]
